Glenmark Pharmaceuticals launches MINYM gel for acne treatment

Glenmark Pharmaceuticals has launched a topical Minocycline 4% Gel under the brand name MINYM in India for the treatment of moderate to severe acne.

According to the Indian pharma company, MINYM is a potent antibacterial gel which provides a strong anti-inflammatory action. Compared to the available topical antibacterial formulations, its topical Minocycline 4% Gel offers the lowest MIC90, claimed Glenmark Pharmaceuticals.

Glenmark Pharmaceuticals launches MINYM gel for acne treatment. Photo courtesy of Kjerstin Michaela Noomi Sakura Gihle Martinsen Haraldsen from Pixabay.

Alok Malik — Glenmark Pharmaceuticals Group Vice President and Head, India Formulations, said: “Glenmark is a leader in the dermatology segment in India and has been at the forefront in providing access to the latest treatment options to the patients.

“We are proud to introduce the first topical Minocycline-based – MINYM Gel, in India; proven for its potent antibacterial effect, anti-inflammatory action and lowest resistance, as a treatment option to patients aged 9 years and above suffering from acne.”